Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding
An. bras. dermatol
;
90(3): 367-375, May-Jun/2015. tab
Article
Dans Anglais
| LILACS
| ID: lil-749653
ABSTRACT
Abstract Psoriasis is a chronic inflammatory disease that affects primarily the skin and joints, with a worldwide incidence of 2-3%. Fifty percent of patients are women, most still diagnosed during childbearing years. Currently,the estimate is that up to 107 thousand deliveries are performed annually in women with psoriasis, a percentage of them in women with moderate to severe disease. Fetal risks in pregnant women with psoriasis derive both from maternal disease and the medications used to control the illness. The purpose of this review is to study the effect of the main drugs used in the treatment of psoriasis and psoriatic arthritis during pregnancy and lactation, with particular focus on disease-modifying anti-rheumatic biological drugs, biological therapies, immunobiologics or biologics.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Complications de la grossesse
/
Psoriasis
/
Allaitement naturel
/
Lactation
/
Arthrite psoriasique
/
Produits dermatologiques
Type d'étude:
Etude d'étiologie
/
Facteurs de risque
Limites du sujet:
Femelle
/
Humains
/
Grossesse
langue:
Anglais
Texte intégral:
An. bras. dermatol
Thème du journal:
Dermatologie
Année:
2015
Type:
Article
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
Hospital das Forças Armadas/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS